IK

Imrana Shoaib Khan - Profile

Imrana Shoaib Khan, Director and Designated Partner, with 6 companies.

About Imrana Shoaib Khan

Imrana Shoaib Khan has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Indu Hospitals And Research Centre Private Limited and Apy Medi Services Private Limited. Formerly with 2 companies, such as Apy Medi Services Private Limited and Indu Hospitals And Research Centre Private Limited. Engaged in General Business, Healthcare.

Current Companies 4
Past Companies 2
Total Affiliations 6
Oldest Company Age 32
Companies Associated with Imrana Shoaib Khan
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Imrana Shoaib Khan?

Imrana Shoaib Khan has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Indu Hospitals And Research Centre Private Limited and Apy Medi Services Private Limited. Formerly with 2 companies, such as Apy Medi Services Private Limited and Indu Hospitals And Research Centre Private Limited. Engaged in General Business, Healthcare.

What is Imrana Shoaib Khan's role in current companies?

Imrana Shoaib Khan is associated with 4 companies as Director and Designated Partner.

What industries does Imrana Shoaib Khan specialize in?

Imrana Shoaib Khan has expertise in General Business, Healthcare.

How many years of experience does Imrana Shoaib Khan have?

Imrana Shoaib Khan has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available